Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
SLC30A10 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
SLC30A10 May be involved in zinc transport out of the cell, being a zinc-efflux transporter. Belongs to the cation diffusion facilitator (CDF) transporter (TC 2.A.4) family. SLC30A subfamily. 3 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Transporter, SLC family; Membrane protein, multi-pass; Membrane protein, integral; Transporter
Cellular Component: integral to membrane; plasma membrane
Molecular Function: cation transmembrane transporter activity
Biological Process: zinc ion transport
Reference #:  Q6XR72 (UniProtKB)
Alt. Names/Synonyms: DKFZp547M236; SLC30A10; solute carrier family 30 (zinc transporter), member 10; Solute carrier family 30 member 10; solute carrier family 30, member 10; Zinc transporter 10; zinc transporter 8; ZnT-10; ZNT10; ZNT8; ZRC1
Gene Symbols: SLC30A10
Molecular weight: 52,684 Da
Basal Isoelectric point: 6.28  Predict pI for various phosphorylation states
Select Structure to View Below

SLC30A10

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  Pfam  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 2 S187-p ADPTAPGsDSAVtLR
0 4 T192-p PGsDSAVtLRGTSVE
0 1 K472 DHGQSLNKTQEDQCY
  mouse

 
S179-p ATATAPGsGTAVtLR
T184-p PGsGTAVtLRGSSAG
K457-u EQGQTLSkTQERQHY
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.